DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
26.65B
Market cap26.65B
Price-Earnings ratio
38.37
Price-Earnings ratio38.37
Dividend yield
Dividend yield
Average volume
5.32M
Average volume5.32M
High today
$69.31
High today$69.31
Low today
$65.97
Low today$65.97
Open price
$68.95
Open price$68.95
Volume
6.83M
Volume6.83M
52 Week high
$93.25
52 Week high$93.25
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

The current DexCom(DXCM) stock price is $66.95, with a market capitalization of 26.65B. The stock trades at a price-to-earnings (P/E) ratio of 38.37.

On 2025-12-12, DexCom(DXCM) stock moved within a range of $65.97 to $69.31. With shares now at $66.95, the stock is trading +1.5% above its intraday low and -3.4% below the session's peak.

Trading activity shows a volume of 6.83M, compared to an average daily volume of 5.32M.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $93.25 and a low of $54.11.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $93.25 and a low of $54.11.

DXCM News

Nasdaq 1d
Interesting DXCM Put And Call Options For January 2026

Investors in DexCom Inc (Symbol: DXCM) saw new options begin trading today, for the January 2026 expiration. At Stock Options Channel , our YieldBoost formula h...

Interesting DXCM Put And Call Options For January 2026
TipRanks 2d
Citi ups DexCom target, adds ‘upside 90-day catalyst watch’

Citi raised the firm’s price target on DexCom (DXCM) to $77 from $75 and keeps a Buy rating on the shares. Citi also opened an “upside 90-day catalyst watch” on...

Simply Wall St 2d
DexCom: Reassessing Valuation After Launch of Dexcom Academy for Healthcare Professionals

DexCom (DXCM) just rolled out Dexcom Academy, a tailored learning platform for healthcare professionals that could quietly reshape how its continuous glucose mo...

DexCom: Reassessing Valuation After Launch of Dexcom Academy for Healthcare Professionals

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
15.2%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.